Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine

Abstract

Cyclin-dependent kinase 2 (CDK2), a member of Cyclin-dependent kinases (CDKs), plays an important role in cell division and DNA replication. It is regarded as a desired target to treat cancer and tumor by interrupting aberrant cell proliferation. Compared to lower subtype selectivity of CDK2 ATP-competitive inhibitors, CDK2 allosteric inhibitor with higher subtype selectivity has been used to treat CDK2-related diseases. Recently, the first crystal structure of CDK2 with allosteric inhibitor has been reported, which provides new opportunities to design pure allosteric inhibitors of CDK2. The binding site of the ATP-competition inhibitors and the allosteric inhibitors are partially overlapped in space position, so the same compound might interact with the two binding sites. Thus a novel screening strategy was essential for the discovery of pure CDK2 allosteric inhibitors. In this study, pharmacophore and molecular docking were used to screen potential CDK2 allosteric inhibitors and ATP-competition inhibitors from Traditional Chinese Medicine (TCM). In the docking result of the allosteric site, the compounds which can act with the CDK2 ATP site were discarded, and the remaining compounds were regarded as the potential pure allosteric inhibitors. Among the results, prostaglandin E1 and nordihydroguaiaretic acid (NDGA) were available and their growth inhibitory effect on human HepG2 cell lines was determined by MTT assay. The two compounds could substantially inhibit the growth of HepG2 cell lines with an estimated IC 50 of 41.223 µmol/L and 45.646 µmol/L. This study provides virtual screening strategy of allosteric compounds and a reliable method to discover potential pure CDK2 allosteric inhibitors from TCM. Prostaglandin E1 and NDGA could be regarded as promising candidates for CDK2 allosteric inhibitors.

Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches

“…LB techniques are generally used in the prefiltering step, as illustrated in different works that have exploited 2D fingerprints [ 81 , 82 ], 3D molecular similarity [ 83 , 84 , 85 ] and pharmacophore models [ 86 , 87 , 88 ]. To enhance the drug-likeness of the compounds, knowledge-based in silico ADMET or pan-assay interference compounds (PAINS; [ 89 ]) filters can also be applied.…”

Synthesis, molecular modeling and anticancer activity of new coumarin containing compounds

“…CDKs have a critical role in the control of cell division so deregulation of CDKs can lead to abnormal processes and numerous human diseases, most notably cancer and tumors. Therefore, suppression of CDKs activity serves as an ideal therapeutic strategy for cancer and tumor by interrupting aberrant cell proliferation (Lu et al, 2016). A new class of drugs, termed CDK inhibitors, has been studied in preclinical and now clinical trials.…”

Discovery of Potential Inhibitors of Squalene Synthase from Traditional Chinese Medicine Based on Virtual Screening and In Vitro Evaluation of Lipid-Lowering Effect

“…Then cell viabilities were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method [ 58 ]. In 96-well plates, HepG2 cells were seeded for 24 h at a density 2 × 10 4 cells/well, and then incubated at various concentrations of the compounds for another 24 h. Then, each well was treated with 200 uL MTT working solution (5 mg·mL −1 ) and cultured for a further 4 h. After removing the MTT, 150 uL dimethylsulphoxide (DMSO) was added to each well for terminating response, and the plate was set to the table shaker for 5 min at a low speed.…”